ABBOTINDIABSEAbbott India LtdMediumNeutral
Announced Wed, 13 May · 11:00 IST

Postal Ballot Notice - Disclosure under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Management Changes View source PDF

ABBOTINDIA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.0%1-day move
₹26950.00
prior close
₹26975.00
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1+0.1+1.1+0.3+2.0+3.7+3.4+3.2+1.9+3.4-4.0-2.8+1.7
Up moveDown movePending
AI summary

Abbott India Limited is seeking shareholder approval via postal ballot for the appointment of two directors. Mr. James Wenner, who is Vice President and Treasurer at Abbott Laboratories USA (parent company), is being appointed as a Non-Executive Director liable to retire by rotation. Mr. Neeraj Jain, a Chartered Accountant and Company Secretary with over 30 years of experience at Johnson & Johnson and Hindustan Unilever, is being appointed as an Independent Director for a term of 3 years. Mr. Neeraj Jain's appointment fills the vacancy created after Ms. Anisha Motwani's second term as Independent Director completed on April 24, 2026. Both appointments were initially made as Additional Directors in April 2026 and are now being regularized through this shareholder vote. Remote e-voting runs from May 18, 2026 to June 16, 2026.

Likely market impact

The appointment of Mr. Wenner brings Abbott group's senior finance leadership to the India board, while Mr. Neeraj Jain's appointment strengthens the board with experienced independent oversight. Both appointments are routine governance matters and likely to be approved by shareholders.